[home]
[thesaurus]
Click Here to return To Results
Antithrombotic Therapy and Bleeding Risk in a Prospective Cohort Study of Patients with Cerebral Cavernous Malformations
Stroke 43:3196-3199, Schneble, H.,et al, 2012
See this aricle in Pubmed
Article Abstract
Our observational data suggest that long-term antithrombotic treatment by antiplatelet drugs or warfarin does not increase the frequency of CCM-related hemorrhage. Patients harboring single or multiple CCMs suffering ischemic stroke or heart disease should not be withheld antithrombotic therapy.
Related Tags
(click to filter results - removes previous filter)
anticoagulant,treatment
aspirin
cavernous hemangioma
complications
coumarin
intracerebral hemorrhage
malformation,vascular
malformation,vascular,cerebral
platelet inhibiting drugs
risk factors
safety
Click Here to return To Results